PHN

All Eyes on Spring Training After Winter CPHD Cohort Sets New Record with The Passive House Network

Retrieved on: 
Wednesday, March 27, 2024

NEW YORK, March 27, 2024 /PRNewswire-PRWeb/ -- On April 18th, a new cohort of students will formally begin their studies in the Certified Passive House Designer (CPHD) course, hosted by the Passive House Network (PHN). They'll follow in the footsteps of this year's Winter Cohort. Nearly 60 students strong, it's the largest cohort PHN has enrolled since the organization was founded in 2011.

Key Points: 
  • Certified Passive House Designer Students Enroll in Record Numbers, learning the Principles of Passive House Design Across the Country.
  • NEW YORK, March 27, 2024 /PRNewswire-PRWeb/ -- On April 18th, a new cohort of students will formally begin their studies in the Certified Passive House Designer (CPHD) course, hosted by the Passive House Network (PHN).
  • Created for architects, engineers, consultants, developers, and policymakers, the CPHD course instructs students in the principles of Passive House design.
  • For more information on courses from the Passive House Network, visit https://passivehousenetwork.org/ or email [email protected] .

Emergency Nurses Report Barriers to Talking with Patients about Serious Illnesses

Retrieved on: 
Monday, March 11, 2024

SCHAUMBURG, Ill., March 11, 2024 /PRNewswire/ -- Three-quarters of patients presenting to an ED with a serious illness do so in the last six months of their life. Being able to have conversations around end-of-life care is crucial so that the nurses can provide care consistent with the patient's wishes.

Key Points: 
  • Being able to have conversations around end-of-life care is crucial so that the nurses can provide care consistent with the patient's wishes.
  • Emergency nurses are well-positioned to have those conversations and coordinate care, but nearly 68 percent reported they will encounter barriers while having those conversations according to a study published in the March issue of the Journal of Emergency Nursing.
  • "Emergency nurses are in a unique position where they may be required to have end-of-life conversations with patients at a moment's notice," said Journal of Emergency Nursing Editor-in-Chief Anna Valdez, PhD, RN, PHN, CEN, CFRN, CNE, FAEN, FAADN.
  • "It's imperative that emergency nurses are prepared to have meaningful end-of-life discussions with patients and their loved ones."

CCHF Releases Animated Video: "Introducing The Wedge"

Retrieved on: 
Monday, January 29, 2024

ST. PAUL, Minn. , Jan. 29, 2024 /PRNewswire/ -- Citizens' Council for Health Freedom (CCHF) is announcing today a new animated video to promote The Wedge of Health Freedom®, a nationwide online directory of independent, cash-based practices.

Key Points: 
  • ST. PAUL, Minn. , Jan. 29, 2024 /PRNewswire/ -- Citizens' Council for Health Freedom (CCHF) is announcing today a new animated video to promote The Wedge of Health Freedom® , a nationwide online directory of independent, cash-based practices.
  • "CCHF is excited to introduce this animated video as a tool to educate patients and doctors about a patient-centered alternative to today's impersonal, restrictive health care system.
  • The Wedge offers Americans a vision of where health care needs to go – ethically, medically, and compassionately," adds Brase.
  • CCHF calls on all Americans to join The Wedge and move toward a future of patient-centered, affordable, interference-free, and confidential medical care.

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 10, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 10, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 10, Status: Authorised

Study Considers the Needs of Cardiac Arrest Patients' Families in ED

Retrieved on: 
Monday, November 6, 2023

SCHAUMBURG, Ill., Nov. 6, 2023 /PRNewswire/ -- When a patient, regardless of age, experiences cardiac arrest, often the entire family is impacted and involved in care.

Key Points: 
  • Featured in the November issue of the Journal of Emergency Nursing, a new study – "What Are the Care Needs of Families Experiencing Sudden Cardiac Arrest?
  • A Survivor- and Family-Performed Systematic Review, Qualitative Meta-synthesis, and Clinical Practice Recommendations" – explores the ways emergency nurses can support families and their involvement in cardiac arrest patient care.
  • As more cardiac arrest care systems are created to address the needs of patients, family members and survivors, the study's authors sought to review existing research to help clarify the roles emergency nurses play in prearrest, intra-arrest and post-arrest periods for the family of cardiac arrest patients.
  • "I lost a family member to a sudden cardiac arrest event.

Herzing University Launches Innovative Public Health Concentration in Nursing

Retrieved on: 
Monday, September 25, 2023

MILWAUKEE, Sept. 25, 2023 /PRNewswire/ -- Herzing University, an accredited, private nonprofit institution, announced today the addition of a new Public Health-focused concentration within its Master of Science in Nursing (MSN) program. The MSN-PH degree will offer two tracks — a classic pathway to advance from a Bachelor of Science in Nursing to MSN-PH and an accelerated RN-to-MSN-PH program for current registered nurses (RN) who have completed an Associate of Science in Nursing (ASN) degree.

Key Points: 
  • MILWAUKEE, Sept. 25, 2023 /PRNewswire/ -- Herzing University, an accredited, private nonprofit institution, announced today the addition of a new Public Health-focused concentration within its Master of Science in Nursing (MSN) program .
  • "Public health nurses play a pivotal role in addressing the health needs of populations, from local neighborhoods to national policy initiatives.
  • By adding a Public Health concentration to our existing MSN program, we've designed a pathway that can lead this essential charge toward better health for all."
  • Earning a master's degree can help current healthcare workers qualify for upper-level managerial and leadership positions in public health nursing.

Research explores emergency nurses' decision-making in obstetrical care

Retrieved on: 
Wednesday, September 13, 2023

SCHAUMBURG, Ill., Sept. 13, 2023 /PRNewswire/ --  Emergency nurses need additional knowledge of abortion-limiting legislation as well as the related clinical, ethical and legal implications for both emergency care staff and their patients, a study published in the September issue of the Journal of Emergency Nursing found.

Key Points: 
  • The findings also call attention to the increase in pregnant patients seeking care in emergency departments as the number of "OB deserts"—regions with limited or absent perinatal care—grows.
  • Through interviews with ED nurses, the study explored the clinical decision-making processes of emergency nurses caring for patients with obstetrical emergencies in the context of limited or no access to abortion care.
    "
  • Second, EDs are seeing more and more obstetric emergencies in communities where no OB services are available," said Wolf, who is also Director, Emergency Nursing Research at ENA.
  • The Journal of Emergency Nursing, ENA's peer-reviewed academic journal, is published six times a year with original research and updates from the emergency nursing specialty, while also covering practice and professional issues.

Scilex Holding Company Announces Results From Independent Market Research Study Conducted with Pain Specialists and HCPs Treating Post-Herpetic Neuralgia (PHN) Pain on ZTlido®

Retrieved on: 
Thursday, July 13, 2023

Neurologists and HCPs estimate that they will prescribe ZTlido® to 64% of their patients in cases where they are using market leading neuropathic pain products.

Key Points: 
  • Neurologists and HCPs estimate that they will prescribe ZTlido® to 64% of their patients in cases where they are using market leading neuropathic pain products.
  • 1
    Unlike conventional lidocaine patches, ZTlido® utilizes ZTech technology—an advanced adhesion and delivery system designed for a lidocaine patch, allowing it to efficiently deliver 12 hours of pain relief for patients.
  • ZTlido® new prescriptions (NRxs) grew by 34% and total prescriptions (TRxs) grew by 27% in YTD Q2-2023, compared to Q2-2022.
  • NRxs grew by 38% and TRxs grew by 31% in YTD Q2-2023, compared to YTD 2022.

Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis

Retrieved on: 
Friday, June 2, 2023

The data adds to the growing evidence supporting all dimensions of the company’s comprehensive Precision Care Solution for MS.

Key Points: 
  • The data adds to the growing evidence supporting all dimensions of the company’s comprehensive Precision Care Solution for MS.
  • “The robustness of learned protein signatures across datasets is reassuring evidence for the clinical utility of this methodology,” Dr. Foley said.
  • Discrepancies in clinical impressions, treatment recommendations, and follow-up orders may significantly impact patient outcomes and cost of care.
  • The posters and oral presentation presented by Octave at this year’s CMSC Annual Meeting showcase the growing breadth of data supporting its Precision Care Solution.

Scilex Holding Company Enters Master Distributor Agreement Among CH Trading Group LLC (“CHT” or “Territories Distributor”) and Farouk, Maamoun Tamer & Co. (“Master Distributor”) For the Distribution of ZTlido® in the Kingdom of Saudi Arabia

Retrieved on: 
Wednesday, May 31, 2023

Designated Territories will include Kingdom of Saudi Arabia.

Key Points: 
  • Designated Territories will include Kingdom of Saudi Arabia.
  • ZTlido® is a lidocaine topical system approved for the relief of neuropathic pain associated with post-herpetic neuralgia (PHN).
  • ZTlido® was strategically designed to address the limitations of current prescription lidocaine patches by providing significantly improved adhesion and continuous pain relief throughout the 12-hour administration period.
  • “This agreement represents another critical milestone towards bringing our innovative non-opioid pain management medicines to people around the world,” said Jaisim Shah, President and Chief Executive Officer of Scilex.